SUTRO BIOPHARMA, INC. (STRO) Debt Components
- 2023-12-31: Debt, CurrentUSD $4.06M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
- 2023-12-31: Debt, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
- 2023-12-31: Debt, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $4.06M; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD $4.06M.
- 2023-09-30: Debt, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
SUTRO BIOPHARMA, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-term Debt, Gross USD | Debt Instrument, Interest Rate During Period pure | Debt Instrument, Unamortized Discount USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $4.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 11.49% | (m) | (m) |
| 2023-12-31 | (m) | $4.06M | $0.00 | $4.06M | (m) | (m) | (m) | $3.12M | (m) | (m) | $-936.00K |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 11.38% | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 11.76% | (m) | (m) |
| 2023-09-30 | $7.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 11.19% | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 11.44% | (m) | (m) |
| 2023-06-30 | $10.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 10.95% | (m) | (m) |
| 2023-03-31 | $13.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 8.72% | (m) | (m) |
| 2022-12-31 | $12.50M | $12.50M | $3.77M | $16.27M | (m) | (m) | (m) | $15.62M | (m) | (m) | $-646.00K |
| 2022-12-31 | (m) | (m) | (m) | (m) | $13.31M | $4.13M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 8.26% | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.63% | (m) | (m) |
| 2022-09-30 | $12.50M | (m) | $6.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 8.07% | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.07% | (m) | (m) |
| 2022-06-30 | $12.50M | (m) | $9.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.07% | (m) | (m) |
| 2022-03-31 | $12.50M | (m) | $12.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 8.07% | (m) | (m) |
| 2021-12-31 | $9.38M | $9.38M | $15.74M | $25.11M | (m) | (m) | (m) | $25.00M | (m) | (m) | $-113.00K |
| 2021-12-31 | (m) | (m) | (m) | (m) | $11.17M | $13.31M | $4.13M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 8.07% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.07% | (m) | (m) |
| 2021-09-30 | $6.25M | (m) | $18.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 8.07% | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.07% | (m) | (m) |
| 2021-06-30 | $3.12M | (m) | $21.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.07% | (m) | (m) |
| 2021-03-31 | (m) | (m) | $24.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 8.08% | (m) | (m) |
| 2020-12-31 | (m) | (m) | $24.55M | $24.55M | (m) | (m) | (m) | $25.00M | (m) | (m) | $455.00K |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 8.08% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.07% | (m) | (m) |
| 2020-09-30 | (m) | (m) | $24.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 8.08% | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.07% | (m) | (m) |
| 2020-06-30 | (m) | (m) | $24.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.09% | (m) | (m) |
| 2020-03-31 | (m) | (m) | $24.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 8.72% | (m) | (m) |
| 2019-12-31 | $1.00M | (m) | $8.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 8.80% | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.64% | (m) | (m) |
| 2019-09-30 | $5.84M | (m) | $5.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 8.88% | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.87% | (m) | (m) |
| 2019-06-30 | $5.81M | (m) | $7.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.90% | (m) | (m) |
| 2019-03-31 | $5.77M | (m) | $8.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 8.39% | (m) | (m) |
| 2018-12-31 | $4.72M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $14.72M | $5.00M | $6.00M | $4.00M | $15.00M | (m) | $276.00K | (m) |
| 2018-09-30 | $3.18M | (m) | $11.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $14.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |